Wolfgang Erwin Thasler

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Marcus Bahra · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
2. Katharina Tschoep · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
3. Rainer Fietkau · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
4. Pirus Ghadjar · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
5. Rolf Dieter Issels · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
6. Lucjan Stanislaw Wyrwicz · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
7. Wolfram Trudo Knoefel · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
8. Volker Heinemann · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
9. Uwe Pelzer · 1 shared paper, 2023 · strength 0.11
   • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
10. Helmut Oettle · 1 shared paper, 2023 · strength 0.11
    • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
11. Jens Werner · 1 shared paper, 2023 · strength 0.11
    • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
12. Stefan Hubert Boeck · 1 shared paper, 2023 · strength 0.11
    • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
13. Christiane J. Bruns · 1 shared paper, 2023 · strength 0.11
    • Paper Regional hyperthermia with cisplatin added to gemcitabine versus gemcitabine in patients with resected pancreatic ducta… DOI 10.1016/j.ejca.2022.12.009↗
14. Shuai Yin · 1 shared paper, 2017 · strength 0.08
    • Paper Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: di… DOI 10.1007/s00432-017-2434-2↗
15. Hao Feng · 1 shared paper, 2017 · strength 0.08
    • Paper Homogeneous pancreatic cancer spheroids mimic growth pattern of circulating tumor cell clusters and macrometastases: di… DOI 10.1007/s00432-017-2434-2↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.